Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial comparing prochlorperazine to acetaminophen, aspirin, and caffeine for acute migraine; study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)
  • Aspirin (Aspirin)
  • Caffeine (caffeine)
  • prochlorperazine (prochlorperazine)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Migraine Headaches | Phase 4 | Status: TERMINATED | Results posted: 2020-03-18